Cargando…
Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients
STUDY DESIGN: A prospective cohort. PURPOSE: To report the short and long term outcomes of fluoroscopically guided lumbar transforaminal epidural steroid injection (TFESI) in degenerative lumbar spondylolisthesis (DLS) patients. OVERVIEW OF LITERATURE: TFESI has been widely used for the treatment of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Spine Surgery
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996334/ https://www.ncbi.nlm.nih.gov/pubmed/24761192 http://dx.doi.org/10.4184/asj.2014.8.2.119 |
_version_ | 1782313030840745984 |
---|---|
author | Kraiwattanapong, Chaiwat Wechmongkolgorn, Supaporn Chatriyanuyok, Bangon Woratanarat, Patarawan Udomsubpayakul, Umaporn Chanplakorn, Pongsathorn Keorochana, Gun Wajanavisit, Wiwat |
author_facet | Kraiwattanapong, Chaiwat Wechmongkolgorn, Supaporn Chatriyanuyok, Bangon Woratanarat, Patarawan Udomsubpayakul, Umaporn Chanplakorn, Pongsathorn Keorochana, Gun Wajanavisit, Wiwat |
author_sort | Kraiwattanapong, Chaiwat |
collection | PubMed |
description | STUDY DESIGN: A prospective cohort. PURPOSE: To report the short and long term outcomes of fluoroscopically guided lumbar transforaminal epidural steroid injection (TFESI) in degenerative lumbar spondylolisthesis (DLS) patients. OVERVIEW OF LITERATURE: TFESI has been widely used for the treatment of lumbosacral radicular pains. However, to our knowledge, there has been no study which has evaluated the outcomes of TFESI in patients with DLS. METHODS: The DLS patients received fluoroscopically guided lumbar TFESI with 80 mg of methylprednisolone and 2 mL of 1% lidocaine hydrochloride. Patients were evaluated by an independent observer before the initial injection, at 2 weeks, at 6 weeks, at 3 months, and at 12 months after the injections. Visual analog scale (VAS), Roland 5-point pain scale, standing tolerance, walking tolerance, and patient satisfaction scale were evaluated for outcomes. RESULTS: Thirty three DLS patients treated with TFESI, who were completely followed up, were included in this study. The average number of injections per patient was 1.9 (range from 1 to 3 injections per patient). Significant improvements in VAS and Roland 5-point pain scale were observed over the follow up period from 2 weeks to 12 months. However, the standing and walking tolerance were not significantly improved after 2 weeks. At 2 weeks, the patient satisfaction scale was highest, although, these outcomes declined with time. The DLS patients with one level of spinal stenosis showed significantly better outcome than the DLS patients with two levels of spinal stenosis. Five patients (13%) underwent surgical treatment during the 3 to 12 months follow up. CONCLUSIONS: TFESI provides short term improvements in VAS and Roland 5-point pain scale, standing tolerance, walking tolerance and patient satisfaction scale in DLS patients. In the long term, it improves VAS but limits the improvements in Roland 5-point pain scale, standing tolerance, walking tolerance and patient satisfaction scale. |
format | Online Article Text |
id | pubmed-3996334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Korean Society of Spine Surgery |
record_format | MEDLINE/PubMed |
spelling | pubmed-39963342014-04-23 Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients Kraiwattanapong, Chaiwat Wechmongkolgorn, Supaporn Chatriyanuyok, Bangon Woratanarat, Patarawan Udomsubpayakul, Umaporn Chanplakorn, Pongsathorn Keorochana, Gun Wajanavisit, Wiwat Asian Spine J Clinical Study STUDY DESIGN: A prospective cohort. PURPOSE: To report the short and long term outcomes of fluoroscopically guided lumbar transforaminal epidural steroid injection (TFESI) in degenerative lumbar spondylolisthesis (DLS) patients. OVERVIEW OF LITERATURE: TFESI has been widely used for the treatment of lumbosacral radicular pains. However, to our knowledge, there has been no study which has evaluated the outcomes of TFESI in patients with DLS. METHODS: The DLS patients received fluoroscopically guided lumbar TFESI with 80 mg of methylprednisolone and 2 mL of 1% lidocaine hydrochloride. Patients were evaluated by an independent observer before the initial injection, at 2 weeks, at 6 weeks, at 3 months, and at 12 months after the injections. Visual analog scale (VAS), Roland 5-point pain scale, standing tolerance, walking tolerance, and patient satisfaction scale were evaluated for outcomes. RESULTS: Thirty three DLS patients treated with TFESI, who were completely followed up, were included in this study. The average number of injections per patient was 1.9 (range from 1 to 3 injections per patient). Significant improvements in VAS and Roland 5-point pain scale were observed over the follow up period from 2 weeks to 12 months. However, the standing and walking tolerance were not significantly improved after 2 weeks. At 2 weeks, the patient satisfaction scale was highest, although, these outcomes declined with time. The DLS patients with one level of spinal stenosis showed significantly better outcome than the DLS patients with two levels of spinal stenosis. Five patients (13%) underwent surgical treatment during the 3 to 12 months follow up. CONCLUSIONS: TFESI provides short term improvements in VAS and Roland 5-point pain scale, standing tolerance, walking tolerance and patient satisfaction scale in DLS patients. In the long term, it improves VAS but limits the improvements in Roland 5-point pain scale, standing tolerance, walking tolerance and patient satisfaction scale. Korean Society of Spine Surgery 2014-04 2014-04-08 /pmc/articles/PMC3996334/ /pubmed/24761192 http://dx.doi.org/10.4184/asj.2014.8.2.119 Text en Copyright © 2014 by Korean Society of Spine Surgery http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Kraiwattanapong, Chaiwat Wechmongkolgorn, Supaporn Chatriyanuyok, Bangon Woratanarat, Patarawan Udomsubpayakul, Umaporn Chanplakorn, Pongsathorn Keorochana, Gun Wajanavisit, Wiwat Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients |
title | Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients |
title_full | Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients |
title_fullStr | Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients |
title_full_unstemmed | Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients |
title_short | Outcomes of Fluoroscopically Guided Lumbar Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spondylolisthesis Patients |
title_sort | outcomes of fluoroscopically guided lumbar transforaminal epidural steroid injections in degenerative lumbar spondylolisthesis patients |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996334/ https://www.ncbi.nlm.nih.gov/pubmed/24761192 http://dx.doi.org/10.4184/asj.2014.8.2.119 |
work_keys_str_mv | AT kraiwattanapongchaiwat outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients AT wechmongkolgornsupaporn outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients AT chatriyanuyokbangon outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients AT woratanaratpatarawan outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients AT udomsubpayakulumaporn outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients AT chanplakornpongsathorn outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients AT keorochanagun outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients AT wajanavisitwiwat outcomesoffluoroscopicallyguidedlumbartransforaminalepiduralsteroidinjectionsindegenerativelumbarspondylolisthesispatients |